Capricor Therapeutics Insider Sells Significant Stake Following Option Exercise

Karen Krasney, EVP and General Counsel of Capricor Therapeutics (CAPR), sold approximately $793,000 worth of shares on May 1, 2026. The transaction involved the exercise of options followed by an immediate sale, reducing her direct equity stake by nearly half while retaining a significant portion through remaining stock options.

By Seena Hassouna · Motley Fool · May 10, 2026, 11:01 UTC

Capricor Therapeutics Insider Sells Significant Stake Following Option Exercise

Tickers: $CAPR

Topics: equity_exposure SEC_filing stock_options

Read the full article at Motley Fool

More World news

Jacobs Solutions Declares Quarterly Dividend of $0.36 Per Share Seeking Alpha · November 12, 2026, 16:39 UTC
SOLV Energy Raises Revenue Guidance Following Record Q3 Project Execution Seeking Alpha · November 12, 2026, 16:40 UTC
LiveWorld Reports Q3 Revenue of $2.98 Million and GAAP EPS of -$0.01 Seeking Alpha · November 12, 2026, 16:37 UTC
Jensen Huang Resigns as Nvidia CEO Amid Allegations of Chinese Espionage The Verge · November 12, 2026, 16:30 UTC
Rising New Vehicle Monthly Payments Pose Affordability Risks for Ford and General Motors Motley Fool · November 12, 2026, 16:33 UTC
SpaceX Shares Rise Following Nvidia CEO Jensen Huang Resignation Motley Fool · November 12, 2026, 16:34 UTC
tZERO Receives CFTC Approval for Derivatives Exchange and Clearing Operations PR Newswire · November 12, 2026, 16:36 UTC
enGene Therapeutics Shares Surge Following Positive Mid-Stage Trial Data and Piper Sandler Upgrade Seeking Alpha · November 12, 2026, 16:33 UTC
Former Nvidia CEO Jensen Huang to Testify Before Congress Regarding Export Controls and Security Concerns TechCrunch · November 12, 2026, 16:36 UTC
Nobu Hospitality and Infracorp Partner to Develop Luxury Destination in Bahrain PR Newswire · November 12, 2026, 16:34 UTC